Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration
Assessing Changes in Social Cognition and Personality in Patients with Frontotemporal Lobar Degeneration, Alzheimer's Disease and Parkinson's Disease and Their Effect on the Patient-caregiver Relationship
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Cristina Salvo, BSc, MD
- Phone Number: 416-507-6880
- Email: cristina.salvo@uhn.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5T 2S8
- Toronto Western Hospital, University Health Network
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Patients:
- ability to speak and understand the English language (as questionnaires and tests are only available in English)
Caregivers:
- primary caregiver for a given patient
- ability to speak and understand the English language (as questionnaires and tests are only available in English)
Exclusion Criteria:
Patients and Caregivers:
- history of another neurological disorder
- psychiatric disorder
- severe aphasia (semantic word loss)
- visual deficits requiring correction beyond the use of eyeglasses or contact lenses (intact visual acuity is required for completing both the questionnaires and the emotion evaluation test which consists of video vignettes)
- auditory deficits requiring correction beyond hearing aids (videos have auditory component)
Patients:
- presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body will be excluded as they will be unable to have a MRI scan.
- premenopausal women will be excluded due to the unknown risk of MRIs during pregnancy.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Alzheimer's disease
Observational Study
|
This is an observational study.
|
|
Parkinson's disease
Observational Study
|
This is an observational study.
|
|
Frontotemporal Lobar Degeneration
Observational Study
|
This is an observational study.
|
|
Healthy Controls
Observational Study
|
This is an observational study.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Personality via the Interpersonal Adjectives Scales and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses interpersonal aspects of personality
|
one time visit, through study completion of 3 years
|
|
Personality via the Behaviour Inhibition/Approach Scale (BIS/BAS) and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses the behavioural approach system that regulates appetitive motives, in which the goal is to move toward something desired, and the behavioural avoidance (or inhibition) system that regulates aversive motives, in which the goal is to move away from something unpleasant
|
one time visit, through study completion of 3 years
|
|
Personality via the Big Five Inventory (BFI) and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses the patient's Big Five dimensions (openness, conscientiousness, extraversion, agreeableness, and neuroticism) with respect to past and current behavior
|
one time visit, through study completion of 3 years
|
|
Social cognition via Social Norms Questionnaire and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses the patient's understanding of culturally relevant social norms
|
one time visit, through study completion of 3 years
|
|
Social cognition via Interpersonal Reactivity Index (IRI) and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses the patient's empathy or ability to share in another's mental and emotional experience
|
one time visit, through study completion of 3 years
|
|
Social cognition via Revised Self-Monitoring Scale (RSMS) and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses the patient's sensitivity to the expressive behaviour of others and their ability to monitor their self-presentation
|
one time visit, through study completion of 3 years
|
|
Social cognition via Social Behaviour Observer Checklist and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses behaviors specific to behavioural variant Frontotemporal Dementia (bvFTD) and is helpful in differentiating bvFTD versus Alzheimer's disease.
|
one time visit, through study completion of 3 years
|
|
Neuropsychiatric Inventory (NPI) and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses 12 neuropsychiatric disturbances commonly encountered in patients with dementia, including: delusions, hallucinations, agitation, dysphoria, anxiety, apathy, irritability, euphoria, disinhibition, aberrant motor behaviour, night-time behaviour disturbances, and appetite and eating abnormalities
|
one time visit, through study completion of 3 years
|
|
Clinical Dementia Rating Scale (CDR) and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses 8 domains of global dementia, including: memory, orientation, judgment/problem solving, community affairs, home and hobbies, personal care, behavioural comportment and personality, and language
|
one time visit, through study completion of 3 years
|
|
Functional Activities Questionnaire (FAQ) and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses functional capacity in older adults
|
one time visit, through study completion of 3 years
|
|
Behavioural Tests composite score and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Orientation, Digit span backward and forward, Naming, Modified trails, Benson figure copy, Cerad, Clock draw
|
one time visit, through study completion of 3 years
|
|
Emotion Evaluation Task (EET) portion of The Awareness of Social Inference Test and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses the recognition of six basic emotions commonly recognized across cultures (happiness, sadness, anger, surprise, disgust, fear) as well as a seventh "neutral" emotion.
The emotions are presented via video vignettes.
After viewing each scene, the patient will be asked to choose the emotion represented from a list of seven emotional categories.
The caregiver will complete the test separately, and be asked both to guess the emotion in each vignette, and to speculate on which emotion the patient will guess.
|
one time visit, through study completion of 3 years
|
|
Geriatric Depression Scale (GDS) and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Assesses mood and depression in geriatric patients
|
one time visit, through study completion of 3 years
|
|
Neuroimaging and differences between AD, PD, and FTLD
Time Frame: one time visit, through study completion of 3 years
|
Functional connectivity of networks associated with social cognition and personality
|
one time visit, through study completion of 3 years
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Maria C Tartaglia, M.D., Toronto Western Hospital, UHN; Tanz CRND
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Synucleinopathies
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Mental Disorders
- Metabolic Diseases
- Neurocognitive Disorders
- Dementia
- Tauopathies
- Neurodegenerative Diseases
- Movement Disorders
- Parkinsonian Disorders
- Basal Ganglia Diseases
- TDP-43 Proteinopathies
- Proteostasis Deficiencies
- Alzheimer Disease
- Parkinson Disease
- Frontotemporal Lobar Degeneration
Other Study ID Numbers
Other Study ID Numbers
- 12-0451-BE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.